Shopping Cart
SHARE THIS PRODUCT

Biocombination No. 22

From: Rs.90.00

Scrofula

Scrofula • Helps as a supportive drug in managing scrofula.

Additional information

Size

20 g, 550 g

Package Name

Tablets


BIOPLASGEN/BIOCOMBINATION 22

Indications: Both dry and suppurating scrofulous abscesses. Almost all symptoms of the disease are covered.

Scrofulosis (Scrofula) is a morbid constitutional state of system characterised by indolent glandular tumours that suppurate slowly, heal with difficulty and leave scars.

A well defined skin condition of subcutaneous nodules which gradually enlarge, degenerate, ulcerate and terminate cutaneously. Scrofula as a typical scar tissue is known as Scrofuloderma, lesions commonly occurring about the face, neck through lymph glands. These conditions are also covered by this medicine.

Composition: Calcarea phosphorica 3x, Ferrum phosphoricum 3x, Kalium muriaticum 3x, Silicea 6x in equal proportion.

Proven indications of the ingredients within the claimed sphere of action:

Calcarea phosphorica: Itis indicated for scrophulosis, chlorosis and phthisis covering tubercular glandular enlargements.

Ferrum phosphoricum: Ithas been used in acute exacerbation of tuberculosis, inflammed throat, ulcerated sore throat and restlessness with fever.

Kalium muriaticum: Itis indicated for enlargement of tonsils, lymph glands, sore throat, follicular tonsillitis, vesicles and bursitis. Along with Calcarea phosphorica is covers disturbing symptoms of scrophulosis.

Silicea: Itis used for scrofulous children. It controls abscesses, organic changes and suppurative processes.

Contra-indication: Nil. Dosage: Adults 4 tablets, children 2 tablets, at a time, four times a day at intervals of three hours. Presentation: Tablets of 100 mg. in bottles of 20g.

?

What is Biocombination No. 22?

It is the homoeopathic preparation which is indicated in suppurating scrofulous abscesses, is composed of Calcarea phosphorica 3x, Ferrum phosphoricum 3x, Kali muriaticum 3x, Silicea 6x in equal proportion.

What are uses/benefits of Biocombination No. 22?

Biocombination 22 found useful in both dry and suppurating scrofulous abscesses. Almost all symptoms of the disease are covered by this medicine. Scrofulosis (Scrofula) is a morbid constitutional state of system characterised by indolent glandular tumours that suppurate slowly, heal with difficulty and leave scars. Calcarea phosphorica is indicated for scrophulosis, chlorosis and phthisis covering tubercular glandular enlargements. Ferrum phosphoricum has been used in acute exacerbation of tuberculosis, inflamed throat, ulcerated sore throat and restlessness with fever. Kali muriaticum is indicated for enlargement of tonsils, lymph glands, sore throat, follicular tonsillitis, vesicles and bursitis. Silicea is used for scrofulous children. It controls abscesses, organic changes and suppurative processes.

How should I take Biocombination No. 22?

It should be taken as adults 4 tablets, at a time, four times a day at intervals of three hours or as prescribed by the physician.

What are side effects of Biocombination No. 22?

No side effects are reported.

What precautions to take before taking Biocombination No. 22?

No precautions are needed.

Is Biocombination No. 22 suitable for children?

Yes.

How long should I take Biocombination No. 22?

It should be taken as long as the symptoms are relieved or as prescribed by the physician.

Is it safe to take Biocombination No. 22 during pregnancy?

Yes.

Manufactured in India by Dr. Willmar Schwabe India Pvt. Ltd. A-36, Sector-60, Uttar Pradesh, Noida – 201304.

Country of Origin: India.

Registered office Address: Dr. Willmar Schwabe India Pvt. Ltd. H-36, Green Park Extension, New Delhi, Pin: 110016.

Expiry: 5 years for the date of manufacturing.

Reviews

There are no reviews yet.

Be the first to review “Biocombination No. 22”

Your email address will not be published.

schwabe exit popup banner